Literature DB >> 29197966

Aetiological profile and treatment outcomes of epistaxis at a major teaching hospital: a review of 721 cases.

Brian Carey1, Patrick Sheahan2.   

Abstract

BACKGROUND: Epistaxis is the most prevalent ENT emergency and a significant burden on ENT services. Our objective was to study the incidence and outcomes of patients presenting with epistaxis at a major teaching hospital.
METHODS: A retrospective descriptive study of 721 patients, who presented with epistaxis over a 1-year period, was carried out. Data collected was analysed using SPSS software version 20.
RESULTS: Of the 721 patients, initial treatment consisted of nasal cautery (298), nasal packing (200), or no treatment (223). Fifty-nine patients were admitted. The mean age of admitted patients was 66.8 years and the male to female ratio was 2:1. 69.5% had hypertension and 78% used an antiplatelet/anticoagulation medication. The majority of admitted and return patients were out of hours referrals from ED and the mean admission duration was five nights. Surgical treatment for intractable epistaxis included arterial ligation or endovascular embolisation. Successful treatment was defined as no recurrent epistaxis following pack removal or no readmission with epistaxis within 24 h of hospital discharge. Six hundred forty-four patients had successful treatment.
CONCLUSION: More return and admitted patients presented at out-of-hours times with less clinical staff on site. Most non-admitted patients received no treatment. These factors possibly lead to increased stress on the ENT casualty service. Cautery and nasal packing are the most common treatment modalities in first-time and admitted patients yet result in considerable rates of representation.

Entities:  

Keywords:  Cautery; ENT emergency; Epistaxis; Nasal packing; Otolaryngology; Sphenopalatine artery ligation

Mesh:

Year:  2017        PMID: 29197966     DOI: 10.1007/s11845-017-1721-x

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  15 in total

1.  Occurrence of epistaxis in habitual nose-bleeders and analysis of some etiological factors.

Authors:  M Beran; B Petruson
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1986       Impact factor: 1.538

2.  Hypertension prevalence, awareness, treatment and control in the over 50s in Ireland: evidence from The Irish Longitudinal Study on Ageing.

Authors:  C M Murphy; P M Kearney; E B Shelley; T Fahey; C Dooley; R A Kenny
Journal:  J Public Health (Oxf)       Date:  2015-04-28       Impact factor: 2.341

3.  In vivo antithrombotic effect of aspirin: dose versus nongastrointestinal bleeding.

Authors:  R G Hart; L A Pearce
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

Review 4.  A systematic review of anti-thrombotic therapy in epistaxis.

Authors:  K M Musgrave; J Powell
Journal:  Rhinology       Date:  2016-12-01       Impact factor: 3.681

5.  Is epistaxis evidence of end-organ damage in patients with hypertension?

Authors:  J F Lubianca Neto; F D Fuchs; S R Facco; M Gus; L Fasolo; R Mafessoni; A L Gleissner
Journal:  Laryngoscope       Date:  1999-07       Impact factor: 3.325

Review 6.  Epistaxis: update on management.

Authors:  Louise Melia; Gerald W McGarry
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2011-02       Impact factor: 2.064

7.  Epidemiology of epistaxis in US emergency departments, 1992 to 2001.

Authors:  Daniel J Pallin; Yi-Mei Chng; Mary Patricia McKay; Jennifer A Emond; Andrea J Pelletier; Carlos A Camargo
Journal:  Ann Emerg Med       Date:  2005-07       Impact factor: 5.721

8.  The initial management of epistaxis.

Authors:  R Tanner; M S Harney
Journal:  Ir Med J       Date:  2015-04

9.  Aspirin, nonsteroidal anti-inflammatory drugs, and epistaxis. A regional record linkage case control study.

Authors:  H L Tay; J M Evans; A D McMahon; T M MacDonald
Journal:  Ann Otol Rhinol Laryngol       Date:  1998-08       Impact factor: 1.547

10.  The Rate of Epistaxis Incidence in New-Generation Anticoagulants and Perioperative Approach in Otorhinolaryngological Practices.

Authors:  Ozan Gökdoğan; Ilker Akyildiz; Begum Yetis Sayin; Sercan Okutucu; Ali Cevat Tanalp; Necmi Arslan
Journal:  J Craniofac Surg       Date:  2017-03       Impact factor: 1.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.